Kaj je IMPAIRED HEPATIC FUNCTION v Slovenščini - Slovenski prevod

• okvarjenim delovanjem jeter
• okvaro delovanja jeter
• okvarjeno jetrno funkcijo
• okvaro jetrne funkcije
• motnjami delovanja jeter
• okvarjeno delovanje jeter

Primeri uporabe Impaired hepatic function v Angleški in njihovi prevodi v Slovenski

Impaired hepatic function.
Okvara jetrne funkcije.

Patients with impaired hepatic function:.
Bolniki z jetrno okvaro:.

Impaired hepatic function:.
Okvarjeno delovanje jeter:.

Patients with impaired hepatic function.
Bolniki z okvaro delovanja jeter.

Impaired hepatic function No adjustment of dosage is necessary.
Okvarjeno delovanje jeter Prilagajanje odmerkov ni potrebno.

Patients with impaired hepatic function:.
Bolniki z motnjami delovanja jeter:.

Caution is recommended in patients with severely impaired hepatic function.
Pri bolnikih s hudo okvaro delovanja jeter je potrebna previdnost.

Au Impaired hepatic function:.
Za Okvarjeno delovanje jeter:.

Use in patients with impaired hepatic function.
Uporaba pri bolnikih z okvarjeno jetrno funkcijo.

Impaired hepatic function: atazanavir is metabolised and eliminated primarily by the liver.
Okvarjeno delovanje jeter: atazanavir se večinoma presnavlja in izloča v jetrih..

Patients with impaired hepatic function:.
Bolniki z zmanjšano jetrno funkcijo:.

Studies have not been conducted in patients with impaired hepatic function.
Na bolnikih z okvarjeno jetrno funkcijo študije niso bile opravljene.

In patients with impaired hepatic function, atosiban should be used with caution.
Pri bolnicah z okvaro delovanja jeter je treba atosiban uporabljati previdno.

No studies have been carried out in subjects with impaired hepatic function.
Pri osebah z oslabljenim delovanjem jeter študije niso bile izvedene.

Dosage in patients with impaired hepatic function No dosage adjustment is necessary.
Odmerjanje pri bolnikih z motnjami delovanja jeter Prilagajanje odmerka ni potrebno.

The clearance of sirolimus may be reduced in patients with impaired hepatic function(see section 5.2).
Pri bolnikih z okvarjenim delovanjem jeter je očistek sirolimusa lahko zmanjšan(glejte poglavje 5.2).

In patients with moderately impaired hepatic function, the dose should be restricted to 15 mg daily.
Pri bolnikih z zmerno okvaro delovanja jeter, odmerek ne sme preseči 15 mg dnevno.

The clearance of sirolimus may be reduced in patients with impaired hepatic function(see section 5.2).
Očistek sirolimusa utegne biti pri bolnikih z okvarjeno jetrno funkcijo zmanjšan(glejte poglavje 5. 2).

Patients with impaired hepatic function have increases in plasma concentration of the free fraction of risperidone.
Bolniki z jetrno okvaro imajo zvišano plazemsko koncentracijo proste frakcije risperidona.

The pharmacokinetics of sildenafil in patients with severely impaired hepatic function have not been studied.
Farmakokinetika sildenafila pri bolnikih s hudo jetrno okvaro ni raziskana.

In patients with impaired hepatic function, atosiban should be used with caution(see sections 4.2 and 4.4).
Pri bolnicah z okvaro delovanja jeter je treba atosiban uporabljati previdno(glejte poglavji 4.2 in 4,4).

The pharmacokinetics of sildenafil in patients with severely impaired hepatic function have not been studied.
Farmakokinetika sildenafila pri bolnikih s hudo okvarjenim delovanjem ledvic ni raziskana.

Pharmacokinetics of HYCAMTIN capsules have not been specifically studied in patients with impaired hepatic function.
Farmakokinetike kapsul HYCAMTIN niso posebej raziskali pri bolnikih z okvarjenim delovanjem jeter.

Due to the lack of data in patients with severely impaired hepatic function, these patients should not be treated with lansoprazole.
Zaradi pomanjkanja podatkov, bolnikov s hudo okvaro delovanja jeter ne smemo zdraviti z lansoprazolom.

Hepatic impairment Thiazides should be used with caution in patients with impaired hepatic function.
Okvara jeter Pri uporabi tiazidov pri bolnikih z moteno funkcijo jeter je potrebna previdnost.

Clinical studies have not been performed in patients with impaired hepatic function, however due to its method of administration and very low systemic absorption, no dosage adjustment is required.
Pri bolnikih z okvarjenim delovanjem jeter klinične študije niso bile izvedene, vendar zaradi načina uporabe in zelo nizke sistemske absorpcije prilagajanje odmerkov ni potrebno.

Special patient groups No pharmacokinetic studies have been performed in patients with impaired hepatic function.
Posebne skupine bolnikov Pri bolnikih z okvarjenim delovanjem jeter niso opravili farmakokinetičnih študij.

No dosage adjustment is recommended in patients with impaired hepatic function(see section 5.2).
Pri bolnikih z okvaro jetrne funkcije prilagoditve odmerka posebej ne priporočamo(glejte poglavje 5. 2).

There is insufficient experience of the use of topotecan in patients with severely impaired hepatic function(serum bilirubin≥ 10 mg/ dl).
Z uporabo topotekana ni dovolj izkušenj pri bolnikih s hudo okvarjenim delovanjem jeter(bilirubin v serumu ≥ 10 mg/ dl).